Literature DB >> 17357994

An investigation of two multivariate permutation methods for controlling the false discovery proportion.

Edward L Korn1, Ming-Chung Li, Lisa M McShane, Richard Simon.   

Abstract

Identifying genes that are differentially expressed between classes of samples is an important objective of many microarray experiments. Because of the thousands of genes typically considered, there is a tension between identifying as many of the truly differentially expressed genes as possible, but not too many genes that are not really differentially expressed (false discoveries). Controlling the proportion of identified genes that are false discoveries, the false discovery proportion (FDP), is a goal of interest. In this paper, two multivariate permutation methods are investigated for controlling the FDP. One is based on a multivariate permutation testing (MPT) method that probabilistically controls the number of false discoveries, and the other is based on the Significance Analysis of Microarrays (SAM) procedure that provides an estimate of the FDP. Both methods account for the correlations among the genes. We find the ability of the methods to control the proportion of false discoveries varies substantially depending on the implementation characteristics. For example, for both methods one can proceed from the most significant gene to the least significant gene until the estimated FDP is just above the targeted level ('top-down' approach), or from the least significant gene to the most significant gene until the estimated FDP is just below the targeted level ('bottom-up' approach). We find that the top-down MPT-based method probabilistically controls the FDP, whereas our implementation of the top-down SAM-based method does not. Bottom-up MPT-based or SAM-based methods can result in poor control of the FDP. Copyright (c) 2007 John Wiley & Sons, Ltd.

Mesh:

Year:  2007        PMID: 17357994     DOI: 10.1002/sim.2865

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  17 in total

1.  Relationship between quantitative GRB7 RNA expression and recurrence after adjuvant anthracycline chemotherapy in triple-negative breast cancer.

Authors:  Joseph A Sparano; Lori J Goldstein; Barrett H Childs; Steven Shak; Diana Brassard; Sunil Badve; Frederick L Baehner; Roberto Bugarini; Steve Rowley; Edith A Perez; Lawrence N Shulman; Silvana Martino; Nancy E Davidson; Paraic A Kenny; George W Sledge; Robert Gray
Journal:  Clin Cancer Res       Date:  2011-09-20       Impact factor: 12.531

2.  Isolation rearing impairs wound healing and is associated with increased locomotion and decreased immediate early gene expression in the medial prefrontal cortex of juvenile rats.

Authors:  J B Levine; A D Leeder; B Parekkadan; Y Berdichevsky; S L Rauch; J W Smoller; C Konradi; F Berthiaume; M L Yarmush
Journal:  Neuroscience       Date:  2007-10-24       Impact factor: 3.590

3.  Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer.

Authors:  Joseph A Sparano; Lori J Goldstein; Barrett H Childs; Steven Shak; Diana Brassard; Sunil Badve; Frederick L Baehner; Roberto Bugarini; Steve Rowley; Edith Perez; Lawrence N Shulman; Silvana Martino; Nancy E Davidson; George W Sledge; Robert Gray
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

4.  Identification of microRNAs specifically expressed in hepatitis C virus-associated hepatocellular carcinoma.

Authors:  Giacomo Diaz; Marta Melis; Ashley Tice; David E Kleiner; Lopa Mishra; Fausto Zamboni; Patrizia Farci
Journal:  Int J Cancer       Date:  2013-03-16       Impact factor: 7.396

5.  Use of DNA-damaging agents and RNA pooling to assess expression profiles associated with BRCA1 and BRCA2 mutation status in familial breast cancer patients.

Authors:  Logan C Walker; Bryony A Thompson; Nic Waddell; Sean M Grimmond; Amanda B Spurdle
Journal:  PLoS Genet       Date:  2010-02-19       Impact factor: 5.917

6.  Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors.

Authors:  Hector Hernandez-Vargas; Marie-Pierre Lambert; Florence Le Calvez-Kelm; Géraldine Gouysse; Sandrine McKay-Chopin; Sean V Tavtigian; Jean-Yves Scoazec; Zdenko Herceg
Journal:  PLoS One       Date:  2010-03-17       Impact factor: 3.240

7.  Analysis of DNA microarray expression data.

Authors:  Richard Simon
Journal:  Best Pract Res Clin Haematol       Date:  2009-06       Impact factor: 3.020

8.  Gene expression signature associated with BRAF mutations in human primary cutaneous melanomas.

Authors:  Caroline Kannengiesser; Alain Spatz; Stefan Michiels; Alain Eychène; Philippe Dessen; Vladimir Lazar; Véronique Winnepenninckx; Fabienne Lesueur; Sabine Druillennec; Caroline Robert; Joost J van den Oord; Alain Sarasin; Brigitte Bressac-de Paillerets
Journal:  Mol Oncol       Date:  2008-01-12       Impact factor: 6.603

9.  Three-dimensional mRNA measurements reveal minimal regional heterogeneity in esophageal squamous cell carcinoma.

Authors:  Wusheng Yan; Joanna Shih; Jaime Rodriguez-Canales; Michael A Tangrea; Audrey Player; Lixia Diao; Nan Hu; Alisa M Goldstein; Jing Wang; Philip R Taylor; Scott M Lippman; Ignacio I Wistuba; Michael R Emmert-Buck; Heidi S Erickson
Journal:  Am J Pathol       Date:  2012-12-03       Impact factor: 4.307

10.  Identification of microRNA activity by Targets' Reverse EXpression.

Authors:  Stefano Volinia; Rosa Visone; Marco Galasso; Elda Rossi; Carlo M Croce
Journal:  Bioinformatics       Date:  2009-11-06       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.